CARLOS RUBEN BERRIOS ROSADO

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology PONCE, PR NPI 1508026568

General Payments — all program years on this page

$2,130.94

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 104
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $457.13 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $457.1317

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $364.3712
ABBVIE INC. $73.584
Neurocrine BioSciences, Inc. $19.181

By program year

Program yearAmountRecords
2018 $72.454
2019 $47.743
2020 $234.5711
2021 $398.7626
2022 $581.3632
2023 $338.9311
2024 $457.1317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103315778 ABBVIE INC. $17.01 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103315780 ABBVIE INC. $19.40 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103315782 ABBVIE INC. $19.85 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103315784 ABBVIE INC. $17.32 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150861682 Neurocrine Biosciences, Inc. $19.18 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570447 Teva Pharmaceuticals USA, Inc. $38.67 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570449 Teva Pharmaceuticals USA, Inc. $32.29 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570451 Teva Pharmaceuticals USA, Inc. $9.33 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570455 Teva Pharmaceuticals USA, Inc. $28.26 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570457 Teva Pharmaceuticals USA, Inc. $31.43 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570471 Teva Pharmaceuticals USA, Inc. $30.49 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570473 Teva Pharmaceuticals USA, Inc. $34.54 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570513 Teva Pharmaceuticals USA, Inc. $34.78 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570525 Teva Pharmaceuticals USA, Inc. $30.89 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570541 Teva Pharmaceuticals USA, Inc. $28.83 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570561 Teva Pharmaceuticals USA, Inc. $29.45 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151570569 Teva Pharmaceuticals USA, Inc. $35.41 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.